SOURCE: University General Health System, Inc.

University General Health System, Inc.

July 06, 2011 08:28 ET

University General Health System, Inc. Appoints Donald W. Sapaugh as New President

HOUSTON, TX--(Marketwire - Jul 6, 2011) - University General Health System, Inc. ("University General") (OTCQB: UGHS) (PINKSHEETS: UGHS), a diversified, integrated multi-specialty health delivery system, today announced the appointment of Donald W. Sapaugh to serve as President of the Company, succeeding Dr. Hassan Chahadeh. Mr. Sapaugh was also appointed as a member of University General's board of directors effective June 28, 2011. Dr. Hassan Chahadeh remains University General's Chief Executive Officer and Chairman of the Board of Directors.

Mr. Sapaugh is an experienced business executive in the healthcare industry. With a background of industry service in financial management, he has served as Chief Financial Officer of numerous general acute care and psychiatric hospitals. For ten years beginning in 1986, Mr. Sapaugh served as Chief Executive Officer of Rapha Treatment Centers, one of the largest faith-based psychiatric management companies in the U.S., which managed 49 hospitals in 18 states. In 1996, he founded PremierCare, a company that partnered with more than ten hospitals in six states to help senior adults avoid costly inpatient hospitalizations, before selling his interests in order to focus on senior living. In 2000, Mr. Sapaugh founded TrinityCare Senior Living, a developer and manager of senior living facilities that provides independent living, assisted living and memory care services to seniors, where he continues to serve as President and Chief Executive Officer. Last week, University General announced its acquisition of TrinityCare Senior Living (

Mr. Sapaugh also has extensive experience in the public company sector, having served as Chairman, Chief Executive Officer, board member and consultant to numerous publicly traded companies.

"We are very pleased to announce that Donald W. Sapaugh has joined our Company as President," stated Hassan Chahadeh, M.D., Chairman and Chief Executive Officer of University General Health System, Inc. "Mr. Sapaugh brings a wealth of industry knowledge and experience to University General, along with a valued history in the public markets. His extensive background in facilities development, mergers and acquisitions should serve our Company and its shareholders well as University General pursues an aggressive growth strategy in coming years."

University General Health System, Inc.

University General Health System, Inc. ("University General") is a diversified, integrated multi-specialty health care provider that delivers concierge physician- and patient-oriented services by providing timely, innovative health solutions that are uniquely competitive, efficient, and adaptive in today's health care delivery environment. The Company currently operates one hospital, two free-standing emergency rooms, and one ambulatory surgical center in the Houston area. Also, University General owns three senior living facilities and manages six senior living facilities, and it plans to complete multiple additional acquisitions in 2011 and future years in Houston and other markets.

A fully-reporting company, University General Health System, Inc. is headquartered in Houston, Texas, and its common stock trades on the OTCQB Exchange under the symbol "UGHS".

Forward-Looking Statements

The information in this news release includes certain forward-looking statements that are based upon assumptions that in the future may prove not to have been accurate and are subject to significant risks and uncertainties, including statements related to the future financial performance of the Company. Although the Company believes that the expectations reflected in the forward-looking statements are reasonable, it can give no assurance that such expectations or any of its forward-looking statements will prove to be correct. Factors that could cause results to differ include, but are not limited to, successful execution of growth strategies, product development and acceptance, the impact of competitive services and pricing, general economic conditions, and other risks and uncertainties described in the Company's periodic filings with the Securities and Exchange Commission.

Contact Information

  • For Additional Information, Please Contact:
    RJ Falkner & Company, Inc.
    Investor Relations Counsel
    (830) 693-4400